Navigation Links
Report outlines knowledge gaps for 20 suspected carcinogens
Date:7/15/2010

ATLANTA July 15, 2010 A new report from the American Cancer Society and other world-leading health groups identifies gaps in research for 20 suspected carcinogens whose potential to cause cancer is as yet unresolved. The report is designed to prioritize agents for additional research, and to lead to well-planned epidemiologic or mechanistic studies leading to more definitive classification of these agents.

The report, "Identification of research needs to resolve the carcinogenicity of high-priority IARC carcinogens," is a concerted effort to identify ways to close existing gaps in knowledge for particular agents classified by the International Agency for Research on Cancer (IARC) by identifying information needs and the research to address them for 20 selected agents. The agents are generally in IARC Groups 2A, 2B, and 3. The project originated as part of the National Institute for Occupational Safety and Health's (NIOSH) National Occupational Research Agenda (NORA) to enhance occupational cancer research, and involved collaboration with IARC, the American Cancer Society, the National Institute of Environmental Health Sciences (NIEHS), and the National Cancer Institute (NCI). The effort was co-sponsored by the American Cancer Society. The agents prioritized as needing additional study are:

  • Lead and lead compounds
  • Indium phosphide
  • Cobalt with tungsten carbide
  • Titanium dioxide
  • Welding fumes
  • Refractory ceramic fibers
  • Diesel exhaust
  • Carbon black
  • Styrene-7,8-oxide and styrene
  • Propylene oxide
  • Formaldehyde
  • Acetaldehyde
  • Dichloromethane, methylene chloride (DCM)
  • Trichloroethylene (TCE)
  • Tetrachloroethylene (perc, tetra, PCE)
  • Chloroform
  • Polychlorinated biphenyls (PCBs)
  • Di(2-ethylhexyl) phthalate (DEHP)
  • Atrazine
  • Shift work

"There is significant concern among the public about substances or exposures in the environment that may cause cancer, and there are some common occupational agents and exposure circumstances where evidence of carcinogenicity is substantial but not yet conclusive for humans," said Elizabeth Ward, Ph. D., vice president, Surveillance and Health Policy Research at the American Cancer Society and lead author of the report.. "The objectives of this report are to identify research gaps and needs for 20 agents prioritized for review based on evidence of widespread human exposures and potential carcinogenicity in animals or humans." Dr. Ward, one of the organizers of the meeting and lead author of a version of the report that appears in the journal Environmental Health Perspectives, added that the report highlights the importance of research in occupational settings for the identification of human carcinogens as well as the need for funding and access to populations for this work to continue.


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Related medicine news :

1. Exercise Success for People Over 50: Reports of Improved Fitness, Circulation and Balance
2. New Report: The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels
3. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
4. Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007
5. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
6. New Report: $1 Cigarette Tax Increase Would Raise $418.8 Million for Texas and Cut Youth Smoking
7. New Report: $1 Cigarette Tax Increase Would Raise $18.6 Million for Montana and Cut Youth Smoking
8. New Report: $1 Cigarette Tax Increase Would Raise $24.8 Million for Wyoming and Cut Youth Smoking
9. New Report: $1 Cigarette Tax Increase Would Raise $43.3 Million for Utah and Cut Youth Smoking
10. New Report: $1 Cigarette Tax Increase Would Raise $113.9 Million for Colorado and Cut Youth Smoking
11. New Report: $1 Cigarette Tax Increase Would Raise $65.3 Million for Iowa and Cut Youth Smoking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... VEGAS, NEV. (PRWEB) , ... August 22, 2017 ... ... American Academy of Anti-Aging Medicine recently spoke at a popular international aesthetics conference ... therapy has had on restoring his patients’ health and his growing practice. , ...
(Date:8/22/2017)... ... August 22, 2017 , ... Five Star Glass is new to the Texas market, ... replacement of auto glass for most makes and models, in Grand Prairie, TX, located in ... , They have been a family owned business for the past 40 years with 32 ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Glimpses Of Light”: is a unique ... Of Light” is the creation of published author, J.M. Shepherd, a writer, teacher, traveler, ... to life’s perplexing mysteries. , Shepherd shares, “Love is one of the least understood ...
(Date:8/21/2017)... ... 22, 2017 , ... PracticeMatch, a company that provides online resources , ... and advanced practitioners like nurse practitioners and physician assistants , will ... of this year. The online career fairs will allow job seekers to connect with ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... today announced that it has become the Official Technology Partner of North Country ... AES (Advanced Event Systems) volleyball software, along with providing sport management software ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)...  West Pharmaceutical Services, Inc. (NYSE: WST ... 2017 and updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, ... Net sales at constant currency (organic) grew by 3.9%. ... compared to $0.60 in the prior-year quarter. Second-quarter 2017 ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: